Gongwin Biopharm Co., Ltd. (Gongwin) obtained the approval from the Council of Agriculture, Executive Yuan to initiate exploratory and open clinical pre-trial on dogs (The approval numbers are Prevention Inspection First No.1081415339 and Prevention Inspection First No. 1101401932). Gongwin is a cancer new drug development company which independently researches and develops anti-tumor ablation drugs. Gongwin established Pet Medical Care Division dedicated to the research and development of animal drugs in February 2021, and Pet Biopharm Co., Ltd. in September.